ACR BI-RADS Category 3 Lesions in Women Younger Than 30: Follow-up Outcomes and Factors Associated With Biopsy.
Kanwal MerchantLena OmarJody HayesLindsay ComptonDogan PolatYin XiBasak DoganPublished in: Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine (2021)
BI-RADS 3 lesions identified in our cohort had high biopsy rates and low compliance with no cancers. Our findings suggest that probable fibroadenomas in young women may only warrant abbreviated short-term follow-up at 6-months.